Acute Pancreatitis
Conditions
Keywords
Acute Pancreatitis, biomarkers, severity prediction
Brief summary
The study aims to investigate pathophysiological changes in coagulation in relation to inflammation in patients with acute pancreatitis. Serum and plasma is sampled repeated days from admission. Analysis will be done after recruitment. Specific biomarkers accuracy for prediction of moderate and severer acute pancreatitis will be calculated.
Detailed description
Inclusion criteria: Patients with acute pancreatitis admitted to Skåne University Hospital in Malmö Acute pancreatitis is defined as minimum 2 out of following: amylase levels \>3 times upper reference limit, clinical signs of acute pancreatitis, imaging findings of acute pancreatitis) Exclusion criteria: \<18 years of age \>72 hours from onset of symptom until first sampling Patients with immunosuppression or autoimmune diseases are excluded from som parts of the study. Methods: Serum and plasma is sampled repeatedly during the hospital admission. Pre defined protocols are used for data collections of relevant clinical information. Specific aspects of inflammation, thrombin generation, platelet function and Microparticles will be analysed in serum or plasma during the first consecutive days of acute pancreatitis. Biomarkers for severe disease as well as correlation between inflammation and coagulopathy will be investigated.
Interventions
DIAGNOSTIC_TESTExploratory for different markers
Test biomarkers for development of mild, moderate or severe disease
Sponsors
Region Skane
Lund University
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Acute Pancreatitis, accept informed consent -
Exclusion criteria
More than 72h from onset of symptoms until first sample, patient already included once \-
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Severe acute pancreatitis | 14 days | According to Revised Atlanta which is a consensus document where organ failure (defined by modified Marshall score) less than 48hours or signs of local complications on CT scan defines severity. This is not a scale but a generally used definition according to the paper: Banks PA, et al. Classification of acute pancreatitis-2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102-11. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Moderately Severe Acute Pancreatitis | 14 days | According to Revised Atlanta which is a consensus document where organ failure (defined by modified Marshall score) less than 48hours or signs of local complications on CT scan defines severity. This is not a scale but a generally used definition according to the paper: Banks PA, et al. Classification of acute pancreatitis-2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102-11. |
Countries
Sweden
Contacts
PRINCIPAL_INVESTIGATORSara Regnér, MD, PhD
Region Skåne and Lund University
Outcome results
None listed